A new report showed the ethnic and racial disparities in the patient population of oncology clinical trials. Researchers spent December 2020 to April 2021 examining all United...
Read Post
A novel therapy called CBP501 is the feature of a recent clinical trial for mesothelioma. When paired with chemotherapy drugs cisplatin and pemetrexed, CBP501 increases the...
Read Post
Pain, fatigue and nausea are all common side effects of cancer treatment, including systemic therapy for mesothelioma. Chemotherapy, for instance, takes a mighty toll on the body...
Read Post
One of the challenges of radiation for mesothelioma is damage to lung tissue. The primary tumor for this cancer exists in the lining of the lungs, called the pleura. Aiming...
Read Post
Could there be a new way to assess a mesothelioma case – and therefore, a new way to determine mesothelioma stages? The American Journal of Surgical Pathology published a...
Read Post
Chemotherapy for mesothelioma has new rival systemic therapy: immunotherapy. However, the long-used method for treatment remains effective for some patients. Doctors tested two...
Read Post
The COVID-19 vaccine boosts the immune system and protects people from serious cases of the virus. In many instances, getting vaccinated is the safeguard between life and...
Read Post
Consider how far we’ve come in 20 years. Back in 2002, mesothelioma rates were rising and the FDA hadn’t approved any therapies for this cancer. Little was known about...
Read Post
The holiday season is a heartwarming time for family and friends. Unfortunately, for some, the cheer is dampened by a diagnosis of mesothelioma during the holidays. Around...
Read Post
After months of wishful thinking, we’re finally getting clinical trials testing immunotherapy for peritoneal mesothelioma. Two trials, one at the University of Chicago...
Read Post